Apr 19, 2024

Featuring perspectives from Dr Erika Hamilton, Dr Virginia Kaklamani and Dr Hope S Rugo, including the following topics.

• HER2-Positive Metastatic Breast Cancer — Dr Hamilton (0:00)
• Metastatic Triple-Negative Breast Cancer — Dr Rugo (29:06)
• SABCS® 2023 Review — Dr Kaklamani (45:20)

CME information and select...

Apr 19, 2024

Featuring perspectives from Dr Virginia Kaklamani, Dr Kevin Kalinsky and Dr Joyce O’Shaughnessy, including the following topics.

• Introduction (0:00)
• Localized HER2-Positive and Triple-Negative Breast Cancer — Dr O’Shaughnessy (1:52)
• SABCS® 2023 Review — Dr Kaklamani (31:48)
• Localized ER-Positive Breast Cancer...

Apr 19, 2024

Featuring perspectives from Dr Erika Hamilton, Dr Kevin Kalinsky, Dr Joyce O’Shaughnessy and Dr Hope S Rugo, including the following topics.

• Introduction (0:00)
• Optimal Integration of CDK4/6 Inhibitors into the Management of ER-Positive Metastatic Breast Cancer (mBC) — Dr O’Shaughnessy (5:46)
• Role of Oral...

Mar 26, 2024

• Case: A woman in her mid-50s with ER-positive, PR-negative, HER2 IHC 1+ metastatic breast cancer (mBC), Recurrence Score® (RS) = 35 (0:00)
• Mechanisms of resistance to antiestrogen therapy in HR-positive mBC (2:33)
• Optimal approaches to...

Mar 15, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer | Faculty Presentation 2: Triple-Negative Breast Cancer — Priyanka Sharma, MD

CME information and select...